Drug Research

Crown Bioscience , a global contract research organization and JSR Life Sciences company, announced the opening of a new location in Singapore to expand the company's capacity to serve both global and support local biotech and pharmaceutical companies engaged...

Sandoz, a global leader in generic and biosimilar medicines, signed a Memorandum of Understanding (MoU) to build a new biologics production plant in Lendava, Slovenia. The Sandoz investment is expected to be at least USD 400 million, supporting the company’s...

Charles River Laboratories International, Inc. announced the launch of its off-the-shelf pHelper offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing. It is available immediately in Research...

Simris Alg AB, a European biologics company focused on extracting high value biological active compounds from microalgae and cyanobacteria, announced a framework collaboration agreement with Lonza Ltd, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, to commercialize...

Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective against all primary forms of the disease. Notably, the current bone cancer treatment remains invasive...

In cases when the body is subjected to cancer as well as chronic infections, cytotoxic T immune cells happen to be vital in defining the immune system. Abnormal as well as infected cells need to be eradicated in no...

The National University of Singapore’s Yong Loo Lin School of Medicine has gone on to launch the NUS Medicine Protein Biomarker Discovery Core Facility, which will hand out the Olink Target 96 and 48, Olink Explore 3072, as well...